Overview Incyte is a global, science-driven biopharmaceutical company recognized for its strong growth and deep commitment to advancing therapies in Hematology, Oncology, and Immunology. With a diverse and expanding early pipeline, Incyte is shaping the next generation of targeted and immune-based therapies. Our strength lies in our ability to combine scientific insight with clinical execution, transforming discoveries into impactful medicines for patients worldwide. We are a company in motion, growing, evolving, and investing in early development as a core engine of innovation. At Incyte, every idea begins with science — and every scientist plays a part in shaping what comes next. The Vice President Global Program Head (GPH) – Dermatology, Immunology is responsible for leading cross‑functional teams to advance early‑stage dermatology and immunology programs. This role owns the integrated product development strategy and ensures delivery of programs aligned with corporate priorities, t...